Difference between revisions of "20.109(S21):M3D3"

From Course Wiki
Jump to: navigation, search
(Part 3: Prepare DNA for sequencing reactions)
 
(73 intermediate revisions by one user not shown)
Line 5: Line 5:
 
==Introduction==
 
==Introduction==
  
Now that you have prepared DNA encoding your mutant inverse pericams, we need to produce the proteins so we can assess the affinity and cooperativity of your new protein. Since the last time you were here, your oh-so devoted teaching staff transformed competent bacteria (strain NEB 5α) with your SDM product. Successfully transformed NEB 5α bacteria grew into colonies on ampicillin-containing plates, and two colonies were picked to grow in liquid cultures. The liquid culture of ''E. coli'' serves as a plasmid-generating factory. Today you will purify the plasmids carrying the hopefully mutated inverse pericam gene using a Qiagen mini-prep kit. To ensure that the SDM reaction was successful, and therefore the IPC gene was mutated, you will prepare the purified DNA for sequencing analysis.  Though the NEB 5α cell strain is able to replicate the inverse pericam plasmid DNA, it cannot produce the inverse pericam protein. Therefore, you will transform your IPC mutant plasmids into a new bacterial system, BL21(DE3)pLysS, that ''can'' produce the protein for later analysis.
+
To test the effects of the mutations in the Variant IPC proteins, we will revisit several concepts that were discussed in Mod1. Specifically, a titration curve is used to calculate <math>K_d</math> of IPC binding to calcium!  As a review, consider the simple case of a receptor-ligand pair that are exclusive to each other, and in which the receptor is monovalent. The ligand (L) and receptor (R) form a complex (C), which can be written
  
[[Image:Sp16 M1D4 pRSET vector map.png|thumb|right|350px|'''Vector map of pRSET modified from Invitrogen manual.''']]
+
<center>
 +
<math> R + L  \rightleftharpoons\ ^{k_f}_{k_r}      C </math>
 +
</center>
  
The bacterial expression vector we are using, [http://tools.invitrogen.com/content/sfs/manuals/prset_man.pdf pRSET], encodes many features that make it ideal for our research purposes. To enable selection of bacterial cells that carry the plasmid, an antibiotic cassette (specifically, an ampicillin marker) is included on the vector.  Several features are included to promote protein expression and purification. In the image to the right a schematic representation of these features is shown. The T7 promoter drives expression of the gene that encodes IPC (or your mutated IPC).  To ensure that the transcript is translated into a protein, a Ribosome Binding Site (RBS) is included.  The ATG sequence serves as the transcriptional start and the 6xHis represents the six-histidine residue tag that is used for protein purification via affinity chromatography.
+
At equilibrium, the rates of the forward reaction (rate constant = <math>k_f</math>) and reverse reaction (rate constant = <math>k_r</math>) must be equivalent. Solving this equivalence yields an equilibrium dissociation constant <math>K_d</math>, which may be defined either as <math>k_r/k_f</math>, or as <math>[R][L]/[C]</math>, where brackets indicate the molar concentration of a species. Meanwhile, the fraction of receptors that are bound to ligand at equilibrium, often called ''y'' or &theta;, is <math>C/R_{TOT}</math>, where <math>R_{TOT}</math> indicates total (both bound and unbound) receptors. Note that the position of the equilibrium (''i.e.'', ''y'') depends on the starting concentrations of the reactants; however, <math>K_d</math> is always the same value. The total number of receptors <math>R_{TOT}</math>= [''C''] (ligand-bound receptors) + [''R''] (unbound receptors). Thus,
  
As mentioned above, pRSET encodes the bacteriophage T7 promoter, which is active only in the presence of T7 RNA polymerase (T7RNAP), an enzyme that therefore must be expressed by the bacterial strain used to make the protein of interest. We will use the BL21(DE3)pLysS strain, which has the following genotype: F<sup>-</sup>, ''omp''T ''hsd''SB (r<sub>B</sub><sup>-</sup> m<sub>B</sub><sup>-</sup>) ''gal dcm'' (DE3) pLysS (Cam<sup>R</sup>). In BL21(DE3), T7RNAP is associated with a ''lac'' construct. Constitutively expressed ''lac'' repressor (''lac''I gene) blocks expression from the ''lac'' promoter; thus, the polymerase will not be produced except in the presence of repressor-binding lactose or a small-molecule lactose analogue such as IPTG (isopropyl &beta;-D-thiogalactoside). To reduce ‘leaky’ expression of the protein of interest (in our case, inverse pericam), the pLysS version of BL21(DE3) contains T7 lysozyme, which inhibits basal transcription of T7RNAP. This gene is retained by chloramphenicol selection, while the pRSET plasmid itself (and thus inverse pericam) is retained by ampicillin selection.
+
<center>
<br style="clear:both;"/>
+
<math>\qquad y = {[C] \over R_{TOT}} \qquad = \qquad {[C] \over [C] + [R]} \qquad = \qquad {[L] \over [L] + [K_d]} \qquad</math>
 +
</center>
  
[[Image:Sp16 M1D4 protein expression system.png|thumb|center|600px|'''Overview of protein expression system.''']]
+
where the right-hand equation was derived by algebraic substitution. If the ligand concentration is in excess of the concentration of the receptor, [''L''] may be approximated as a constant, ''L'', for any given equilibrium. Let’s explore the implications of this result:
  
<br style="clear:both;"/>
+
*What happens when ''L'' << <math>K_d</math>?
 +
::&rarr;Then ''y'' ~ <math>L/K_d</math>, and the binding fraction increases in a first-order fashion, directly proportional to ''L''.
  
After completing mini-preps to isolate your plasmid DNA today (two mutant pRSET-IPC candidates), you will prepare the DNA for sequencing analysis, as well as use it immediately for transformation. In order to transform BL21(DE3)pLysS cells with your mutant IPC plasmids, you will first have to make the cells competent, ''i.e.'', able to efficiently take up foreign DNA. With the NEB 5&alpha; strain, we used commercially available competent cells that did not need further treatment prior to DNA addition. Today, you will make chemically competent cells yourself using calcium chloride, then incubate them with plasmid DNA and heat shock them as before prior to plating.  Whether prepared by a company or by you, remember that competent cells are extremely fragile and should be handled gently, ''i.e.'' kept cold and not vortexed.  Bacterial transformation is efficient enough for most lab purposes, resulting in as many as 10<sup>9</sup> transformed cells per microgram of DNA, but even with highly competent cells only 1 DNA molecule in about 10,000 is successfully transformed.
+
*What happens when ''L'' >> <math>K_d</math>?
 +
::&rarr;In this case ''y'' ~1, so the binding fraction becomes approximately constant, and the receptors are saturated.
  
After today's lab session, the teaching staff will pick colonies and set up liquid overnight cultures from your transformed BL21(DE3)pLysS cells. Next time, you will add IPTG to these liquid cultures to induce expression of your mutant proteins, which you will then isolate and characterize.
+
*What happens when ''L'' = <math>K_d</math>?
 +
::&rarr;Then ''y'' = 0.5, and the fraction of receptors that are bound to ligand is 50%. When ''y'' = 0.5, the concentration of free calcium (our [''L'']) is equal to <math>K_d</math>.  
  
==Protocols==
+
The figures below demonstrate how to read <math>K_d</math> from binding curves: 
  
===Part 1: Participate in Comm Lab workshop===
+
'''Simple binding curve''' <br>
 +
The binding fraction ''y'' at first increases linearly as the starting ligand concentration is increased, then asymptotically approaches full saturation (''y''=1). The dissociation constant <math>K_d</math> is equal to the ligand concentration [''L''] for which ''y'' = 1/2.
  
Our communication instructors, Dr. Prerna Bhargava and Dr. Sean Clarke, will join us today for a discussion on preparing a Research proposal presentation.
+
'''Semilog binding curves''' <br>
 +
By converting ligand concentrations to logspace, the dissociation constant is readily determined from the inflection point of the sigmoidal curve. The three curves each represent different ligand species. The middle curve has a <math>K_d</math> close to 10 nM, while the right-hand curve has a higher <math>K_d</math> and therefore lower affinity between ligand and receptor (vice-versa for the left-hand curve).
  
===Part 2: Induce expression of IPC variants===
+
[[File:Sp21 M3D3 binding curves.png|thumb|600px|center|'''Binding curves are used to determine <math>K_d</math>.''' Titration data can be visualized using simple, also referred to as linear, plots (A) or semilog plots (B). In both representations, every ''L'' value is associated with a particular equilbrium value of ''y'', while the curve as a whole gives information on the global equilibrium constant <math>K_d</math>.]]
  
===Part 3: Purify IPC variants===
+
Because inverse pericam has multiple binding sites the IPC-calcium binding is more complicated than the example above. The <math>K_d</math> reported in the IPC reference article by Nagai ''et. al.'' is called an ‘apparent <math>K_d</math>’ because it reflects the overall avidity of multiple calcium binding sites, not their individual affinities for calcium. Normally, calmodulin has a low affinity (N-terminus) and a high affinity (C-terminus) pair of calcium binding sites. However, the E104Q mutant, which is the version of CaM used in inverse pericam, displays low affinity binding at both termini. Moreover, the Hill coefficient, which quantifies cooperativity of binding in the case of multiple sites, is reported to be 1.0 for inverse pericam. This indicates that inverse pericam behaves as if it were binding only a single calcium ion per molecule. Thus, wild-type IPC is well-described by a single apparent <math>K_d</math>.
  
 +
For any given variant IPC, things may be more complicated. Keep in mind that we are not directly measuring calcium binding, but instead are indirectly inferring it based on fluorescence. A change in fluorescence requires the participation not only of calcium, but also of M13. In addition to the four separate calcium binding sites in calmodulin, the M13 binding site influences apparent affinity and apparent cooperativity. In short, be careful about how you describe the meanings of our binding parameters in your data analysis.
  
 +
==Protocols==
  
 +
===Part 1: Participate in Comm Lab workshop===
  
 +
Our communication instructors, Dr. Prerna Bhargava and Dr. Sean Clarke, will join us today for a discussion on preparing a Research proposal presentation.
  
===Part 1: Prepare competent BL21(DE3)pLysS cells===
+
===Part 2: Prepare samples for titration curve===
 
+
#Pick up one 5 mL tube of BL21(DE3)pLysS cells. These cells should be in or near the early- or mid-log phase of growth, which is indicated by an OD<sub>600</sub> value of 0.4-0.8.
+
#Measure the OD<sub>600</sub> value of a 1:10 dilution of your cells (use a total volume of 650-700 &mu;L). If the cells are not yet dense enough, return them to the rotary shaker in the incubator. Remember to balance with another tube! As a rule, your cells should double every 20-30 minutes.
+
#Once your cells have reached the appropriate growth phase, aliquot them into 3 eppendorf tubes each containing 1.5 mL culture volume. Spin for 1 min at max speed (~16,000 rcf/13,000 rpm), aspirate the supernatants, and resuspend in 1.5 mL of ice-cold calcium chloride (100 mM). Note: you can balance these tubes in the centrifuge with three-way symmetry.
+
#*You may find it easiest to resuspend the cells in a small volume first (say, 200 &mu;L), then add the remaining volume of CaCl<sub>2</sub> (e.g., in two steps of 650 &mu;L) and invert the tubes to mix.
+
#Spin again for 1 min. The resultant pellets should occur as streaks down the side of the eppendorf tube, so be very careful not to disturb the cells when aspirating.
+
#This time, resuspend each pellet in 100 μL of CaCl<sub>2</sub>, then pool the cells together in one tube.
+
#*Alternatively, resuspend the first pellet in 300 &mu;L, then use this cell solution to resuspend the next pellet, and the next.
+
#Incubate on ice for 1 h. You can work on Parts 2, 3 and 5 of today's protocols now, as well as assemble the materials for Part 4. Among other things, be sure to label four eppendorfs and '''pre-chill''' them on ice. The labels should indicate a (-) no DNA control, a (+) wild-type IPC transformation control (with minipreps prepared and vetted by the teaching staff), and your two mutant candidate transformations (X#Z -1 and -2).
+
 
+
===Part 2: Mini-prep pRSET-IPC X#Z===
+
The procedure for DNA isolation using small volumes is commonly termed "mini-prep," which distinguishes it from a “maxi-prep” that involves a larger volume of cells and additional steps of purification. The overall goal of each prep is the same -- to separate the plasmid DNA from the chromosomal DNA and cellular debris. In the traditional mini-prep protocol, the media is removed from the cells by centrifugation. The cells are resuspended in a solution that contains Tris to buffer the cells and EDTA to bind divalent cations in the lipid bilayer, thereby weakening the cell envelope. A solution of sodium hydroxide and sodium dodecyl sulfate (SDS) is then added. The base denatures the DNA, both chromosomal and plasmid, while the detergent dissolves the cellular proteins and lipids. The pH of the solution is returned to neutral by adding a mixture of acetic acid and potassium acetate. At neutral pH the SDS precipitates from solution, carrying with it the dissolved proteins and lipids. In addition, the DNA strands renature at neutral pH. The chromosomal DNA, which is much longer than the plasmid DNA, renatures as a tangle that gets trapped in the SDS precipitate. The plasmid DNA renatures normally and stays in solution.  Thus plasmid DNA got effectively separated from chromosomal DNA and proteins and lipids of the cell.
+
 
+
Today you will use a kit that relies on a column to collect the renatured plasmid DNA.  The silica gel column interacts with the DNA while allowing contaminants to pass through the column.  This interaction is aided by chaotropic salts and ethanol, which are added in the buffers.  The ethanol dehydrates the DNA backbone allowing the chaotropic salts to form salt bridge between the silica and the DNA.
+
 
+
#Pick up your two cultures, which are growing in test tubes labeled with your team color. Label two eppendorf tubes to reflect your samples (X#Z 1 and 2).
+
#Vortex the bacteria and pour ~1.5 mL of each candidate into an eppendorf tube. [[Image:Removing cells.jpg|thumb|right|200px|'''Diagram showing how to aspirate the supernatant.'''  Be careful to remove as few cells as possible.]]
+
#Balance the tubes in the microfuge, spin them at maximum speed for 2 min, and remove the supernatants with the vacuum aspirator.
+
#Pour another 1.5 mL of culture onto the pellet, and repeat the spin step.
+
#Resuspend each cell pellet in 250 &mu;L buffer P1.
+
#*Buffer P1 contains RNase so that we collect only our nucleic acid of interest, DNA.
+
#Add 250 &mu;L of buffer P2 to each tube, and mix by inversion until the suspension is homogeneous. About 4-6 inversions of the tube should suffice. You may incubate here for '''up to 5 minutes, but not more'''.
+
#*Buffer P2 contains sodium hydroxide for lysing.
+
#Add 350 &mu;L buffer N3 to each tube, and mix '''immediately''' by inversion (4-10 times).
+
#*Buffer N3 contains acetic acid, which will cause the chromosomal DNA to messily precipitate; the faster you invert, the more homogeneous the precipitation will be.
+
#*Buffer N3 also contains a chaotropic salt in preparation for the silica column purification.
+
#Centrifuge for 10 minutes at maximum speed. Note that you will be saving the '''supernatant''' after this step.
+
#*Meanwhile, prepare 2 labeled QIAprep columns, one for each candidate clone, and 2 trimmed eppendorf tubes for the final elution step.
+
#Transfer the entire supernatant to the column and centrifuge for 1 min. Discard the eluant into a tube labeled ''''Qiagen waste'.'''
+
#Add 0.5 mL PB to each column, then spin for 1 min and discard the eluant into the Qiagen waste tube.
+
#Next wash with 0.75 mL PE, with a 1 min spin step as usual. Discard the ethanol in the Qiagen waste tube.
+
#After removing the PE, spin the mostly dry column for 1 more minute.
+
#*It is important to remove all traces of ethanol, as they may interfere with subsequent work with the DNA.
+
#Add 30 &mu;L of distilled H<sub>2</sub>O pH ~8 to the top center of the column, wait 1 min, and then spin 1 min to collect your DNA.
+
 
+
===Part 4: Transform BL21(DE3)pLysS with pRSET-IPC X#Z===
+
 
+
#Prewarm and dry 4 LB+Amp+Cam plates by placing them in the 37 &deg;C incubator, media side up with the lids ajar. You will perform one transformation for each of your four samples (1 wild-type IPC, 2 mutants, and 1 no-DNA negative-control transformation).
+
#When your competent cells are ready, aliquot 70 &mu;L of cells per pre-chilled eppendorf.
+
#Add 2 &mu;L of the appropriate DNA to each tube. Remember, you are testing plasmid DNA that was prepared from two different colonies for your X#Z mutant, along with DNA from a colony that amplified the pRSET-IPC wild type. You will also perform a no DNA control.
+
#Flick to mix the contents and leave the tubes on ice for at least 5 min.
+
#Heat shock the cells on the 42 &deg;C heat block for 90 s exactly and then put on ice for 2 min.
+
#Move the samples to a rack on your bench, add 0.5 mL of LB media to each one, and invert each tube to mix.
+
#Incubate the tubes in the 37 &deg;C incubator for at least 30 min. This gives the antibiotic-resistance genes some time to be expressed in the transformed bacterial cells.
+
#While you are waiting, label 3 large glass test tubes with your team color and sample names.
+
#*Mix 10 mL LB broth with ampicillin and chloramphenicol, for final antibiotics concentrations of 100 ug/mL and 34 ug/mL, respectively.  Aliquot 3 mL of this mixture  per culture tube.
+
#*The teaching faculty will use these tubes to inoculate your colonies.
+
# Also prepare 4 eppendorf tubes containing 180 μL of LB each. You will use these to dilute your transformed cells 1:10 when you retrieve them from the incubator.
+
#*If you label these tubes with stickers rather than directly on the cap, you can then transfer each sticker to the appropriate plate as you go, saving one labeling step.
+
#*Note that we are reducing the cell concentration because miniprep DNA is much more concentrated than the DNA resulting from mutagenesis; it also does not require repair, further increasing the transformation efficiency.
+
#Plate 200 &mu;L of each (1:10 diluted) transformation mix on a LB+Amp+Cam plate.
+
#*'''Safety reminder:''' After dipping the glass spreader in the ethanol jar, then pass it through the flame of the alcohol burner just long enough to ignite the ethanol.  After letting the ethanol burn off, the spreader may still be very hot, and it is advisable to tap it gently on a portion of the agar plate without cells in order to equilibrate it with the agar. 
+
#Once the plates are done, wrap them with colored tape and incubate them in the 37 &deg;C incubator overnight. One of the teaching faculty will remove them from the incubator and set up liquid cultures for you to use next time.
+
 
+
===Part 1: Cell measurement and IPTG induction===
+
 
+
#Obtain your 6 mL aliquot of BL21(DE3)pLysS cells carrying each mutant plasmid (X#Z 1 and 2) and an aliquot with wild-type inverse pericam. These cells should be in or close to the mid-log phase of growth for good induction, just as they were for transformation. Like last time, check the OD<sub>600</sub> values of your cells (650-700 &mu;L of a 1:10 dilution) until they fall between 0.4 and 0.8. 
+
#*OD values at the higher end should favor more protein production.
+
#Once your cells have reached the appropriate growth phase, set aside - on ice - 1.5 mL of cells from each tube as a no-induction control (no IPTG) sample. You can pellet these cells now or later in the class when you pellet your IPTG-stimulated cells.
+
#Take an aliquot of cold IPTG (0.1 M), and add to your remaining 4.5 mL of cells '''at a final concentration of 1 mM'''. You should prepare two mutant and one wild-type tube.
+
#Return your tubes to the rotary shaker in the 37 &deg;C incubator, and note down the time.
+
#While your IPTG-stimulated cells are producing protein, you will analyze the sequence data and restriction digests of the plasmids they are carrying. At the end of the day, you will choose only one of your X#Z candidates to save (the one that contains your mutation), and aspirate the other into your bleach flask.
+
 
+
===Part 4: Cell observation and collection===
+
 
+
#After 2.5 hours, you will pour 1.5 mL from each tube (from Part 1) into a labeled eppendorf.  Save the other 3 mL!
+
#First, measure the OD<sub>600</sub> values of the three +IPTG samples, according to Part 5 of today's protocol.
+
#Spin the 1.5 mL +IPTG samples for 1 minute at maximum speed. Save the other 3 mL!
+
#Aspirate the supernatant from each eppendorf, using a fresh yellow pipet tip on the end of the glass pipet each time.
+
#Observe the color of each of your pellets and record this observation in your notebook. If the wild-type and both mutant pellets all appear yellow-greenish to the eye, proceed as follows:
+
#*Do NOT toss the rest of the liquid cultures.
+
#*Next, pour 1.5 mL more of the relevant liquid culture on top of each pellet, spin again, and aspirate the supernatant.
+
#*The last 1.5 mL of culture may be aspirated in your vacuum flask, to be later bleached and discarded. 
+
#If one or more of your pellets are white or only dimly colored, please ask one of the teaching staff to show you the room temperature rotary shaker. You will continue to grow your bacteria overnight. Tomorrow morning, the teaching staff will collect your pellets for you and freeze them. As you can see above, '''the +IPTG pellets are from 3 mL of culture''', while the -IPTG pellets come from 1.5 mL of culture.
+
 
+
===Part 5: Preparation for next time===
+
 
+
Next time, you will lyse your bacterial samples to release their proteins, and prepare to run these out on a protein gel. In order to compare the amount of protein in the -IPTG versus +IPTG samples, you would like to normalize by the number of cells. At the end of today, you should have six samples (3 -IPTG no-induction controls and 3 post-induction samples, 1 of each for both X#Z mutants and wild type). Measure the OD<sub>600</sub> of a 1:10 dilution of cells for each finished sample, and write this number down in your notebook and on today's [http://engineerbiology.org/wiki/Talk:20.109%28S16%29:Induce_protein_expression_%28Day5%29 Discussion] page. Then spin down the cells and aspirate the supernatant. Give the cell pellets to the teaching faculty; they will be stored frozen at -20 &deg;C. (Be sure to make a 2X pellet for the +IPTG samples.)
+
 
+
===Part 1: Lysis of cells producing wild-type and mutant IPC===
+
 
+
#You will be given a 2 mL aliquot of room temperature BugBuster buffer (bacterial lysis and protein extraction solution), which contains 0.1% bovine serum albumin (BSA, a stabilizer) and 1:200 protease inhibitor cocktail to guard against protein degradation.
+
#*When you are ready to begin, add 1:1000 of cold nuclease enzyme (obtained from teaching staff) to the BugBuster solution.
+
#Per cell pellet (4 total), add the appropriate volume of enzyme-containing BugBuster and resuspend by pipetting until the solution is relatively homogeneous.
+
#*Resuspend -IPTG samples in 300 &mu;L, and +IPTG samples in 600 &mu;L - do you remember why?
+
#Pipet up and down to mix.
+
#*Be sure the sample is homogenous.  You will likely need to pipet up and down 15-20x.
+
#Incubate the solutions (at room temperature) for 10 minutes on the nutator.
+
#*During this incubation, you may begin the resin preparation described in Part 3.
+
#Finally, centrifuge for 10 minutes at maximum speed and transfer supernatants to fresh tubes.
+
#While one partner completes Part 2, the other partner can begin/continue with the resin preparation in Part 3.
+
 
+
===Part 2: Advance preparation for SDS-PAGE of protein extracts===
+
 
+
#Last time you measured the amount of cells in each of your samples (-IPTG and +IPTG of the wild-type IPC and one correct mutant). (If you ran cultures overnight, the teaching faculty measured the +IPTG samples for you and posted the results.) Look back at your measurements, and find the sample with the lowest cell concentration. Set aside 15 &mu;L of this sample for PAGE analysis in an eppendorf.
+
#For your other three samples, you should take the amount of bacterial lysate corresponding to the same number of cells as the lowest concentration sample. For example, if the OD<sub>600</sub> of your WT -IPTG sample was 0.05, and the OD<sub>600</sub> of your WT +IPTG sample was 0.30, you would take  15 &mu;L of the -IPTG, but only 2.5 &mu;L of the +IPTG sample.
+
#Next, add enough water so the each sample has 15 &mu;L of liquid in it. You might use the table below to guide your work.
+
#Finally, add 3 μL of 6X sample buffer to 15 μL of each of your diluted lysates. These will be stored in the freezer until next time.
+
 
+
<center>
+
{| border="1"
+
! Sample Name       
+
! OD<sub>600</sub>
+
! Sample Volume (&mu;L)
+
! Water Volume (&mu;L)
+
! Total Volume (&mu;L)
+
|-
+
| -IPTG WT
+
|
+
|
+
|
+
|15
+
|-
+
| +IPTG WT
+
|
+
|
+
|
+
|15
+
|-
+
| -IPTG mutant
+
|
+
|
+
|
+
|15
+
|-
+
| +IPTG mutant
+
|
+
|
+
|
+
|15
+
|-
+
|}
+
</center>
+
 
+
===Part 3: Protein purification===
+
 
+
====Part 3A: Nickel-agarose purification====
+
 
+
You will process two samples (+IPTG wild-type and +IPTG mutant IPC) according to the following procedure. <!--
+
You should either time your spins with another group, or balance your tubes with 3-way symmetry.
+
-->
+
'''Keep all buffers on ice when  not in use.''' <font color = CC0066>'''All spins should be performed at 1000 rcf (3300 rpm) for 1 minute.'''</font color>
+
 
+
#The following buffers are aliquoted and located at the front bench:
+
#*Ni-NTA His-bind resin
+
#*1X Ni-NTA Bind Buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>, pH 8.0; 300 mM NaCl; 10 mM imidazole)
+
#*1X Ni-NTA Wash Buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>, pH 8.0; 300 mM NaCl; 20 mM imidazole)
+
#*1X Ni-NTA Elute Buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>, pH 8.0; 300 mM NaCl; 250 mM imidazole)
+
#*''Note'': '''Two special waste streams''' should be created for this affinity purification procedure, (1) nickel waste for the 50% slurry, and (2) imidazole waste for the Bind, Wash, and Elute Buffers.
+
#Gently mix the Ni-NTA His-bind resin to fully resuspend it, then distribute 400 μL of the resin to each of two 2 mL centrifuge tubes.
+
#*Label one tube as wild type and the other as mutant.
+
#Add 1.6 mL (2 x 800 μL) of 1X Ni-NTA Bind Buffer to the Ni-NTA His-bind resin.
+
#*Resuspend the resin by pippeting the solution up and down several times (10-15), then centrifuge (see conditions above).
+
#Carefully remove the supernatant and discard it in the appropriate waste stream.
+
#Add your cleared cell lysate from Part 1 to the resin, then put your tubes on the nutator at 4&deg;C for 30 minutes.
+
#*Be sure to add the wild type and mutant lysates to the correct tubes!
+
#Centrifuge (see conditions above).
+
#Remove the supernatent and discard it in the appropriate waste stream.
+
#Add 1 mL of 1X Ni-NTA Wash Buffer to the resin.
+
#Centrifuge (see conditions above).
+
#Remove the supernatent and discard it in the appropriate waste stream.
+
#Repeat Steps #8-10.
+
#Finally, you will collect your protein. Add 500 &mu;L of Elute Buffer, resuspend, and spin as usual. '''Do not throw away the supernatant!''' Instead, transfer it to a fresh eppendorf tube, labeled “pure IPC X#Z" or “pure IPC WT.”
+
#'''Do not throw away the resin yet either!''' Instead, repeat Step #12 one more time and add the supernatant to the sample collected in Step #12.  You'll have a total of 1 mL of pure wild-type and 1 mL of pure mutant IPC.
+
 
+
====Part 3B: Desalting====
+
 
+
We found from pilot studies that imidazole affects the binding curves of inverse pericams. Thus, you will continue purifying your proteins by removing any low molecular weight compounds.
+
 
+
#For each of your two samples, snap off the bottom of a Zeba column, place in a 15 mL conical tube, and loosen the column's cap.
+
#In the large centrifuge in the cold room across the hall, spin your columns at 1000 rcf (which is 2100 rpm for the rotor inside this centrifuge) for 2 minutes.
+
<!--
+
#*The timing function on this centrifuge does not work! Bring your timer and manually turn the centrifuge off after 2 minutes. Start the timer once the rpm value approaches 2000.
+
-->
+
#*Because we all have to share one centrifuge, ideally spin with at least 2 other groups.
+
#Transfer the column to a fresh 15 mL conical tube, and then gently apply your ~1 mL of protein to the center of the compacted resin.
+
#Repeat the 2-minute spin step just as before.
+
#Immediately after eluting your protein, transfer 10 μL of purified protein to a clean eppendorf tube for assaying protein concentrations (Part 4). Also take 15 μL to a separate eppendorf tube for SDS-PAGE analysis and add 3μL of 6X SDS-PAGE loading dye(give this tube to your instructor).
+
#Then add a 1:100 dilution of 10% BSA to the remaining protein (10 μL of BSA for ~1 mL of protein).
+
 
+
===Part 4: Protein concentration===
+
====Part 4A: Prepare diluted albumin (BSA) standards====
+
#Obtain a 0.25 mL aliquot of 2.0 mg/mL albumin standard stock and a conical tube of diH<sub>2</sub>O from the front bench.
+
#Prepare your standards according to the table below using dH<sub>2</sub>O as the diluent:
+
#*'''Be sure to use 5 mL polystyrene tubes found on the instructors bench when preparing your standards as the volumes are too large for the microcentrifuge tubes.'''
+
<center>
+
{| border="1"
+
! '''Vial''' <br>
+
! '''Volume of diluent (mL)'''
+
! '''Volume (mL) and source of BSA (vial)'''
+
! '''Final BSA concentration (μg/mL)'''         
+
|-
+
| A
+
| 2.25
+
| 0.25 of stock
+
| 200
+
|-
+
| B
+
| 3.6
+
| 0.4 of A
+
| 20
+
|-
+
| C
+
| 2.0
+
| 2.0 of B
+
| 10
+
|-
+
| D
+
| 2.0
+
| 2.0 of C
+
| 5
+
|-
+
| E
+
| 2.0
+
| 2.0 of D
+
| 2.5
+
|-
+
| F
+
| 2.4
+
| 1.6 of E
+
| 1
+
|-
+
| G
+
| 2.0
+
| 2.0 of F
+
| 0.5
+
|-
+
| H
+
| 4.0
+
| 0
+
| Blank
+
|}
+
</center>
+
 
+
====Part 4B: Prepare Working Reagent (WR) and measuring protein concentration====
+
#Use the following formula to calculate the volume of WR required:  (# of standards + # unknowns) * 1.1 = total volume of WR (in mL).
+
#Prepare the calculated volume of WR by mixing the Micro BCA Reagent MA, Reagent MB, and Reagent MC such that 50% of the total volume is MA, 48% is MB, and 2% is MC.
+
#*For example, if your calculated total volume of WR is 100 mL, then mix 50 mL of MA, 48 mL of MB, and 2 mL of MC.
+
#*'''Prepare your WR in a 15 mL conical tube.'''
+
#Pipet 0.5 mL of each standard prepared in Part 4A into clearly labeled 1.5 mL microcentrifuge tubes.
+
#Prepare your protein samples by adding 990 μL of dH<sub>2</sub>O to your 10 μL aliquot of purified protein, for a final volume of 1 mL in clearly labeled 1.5 mL microcentrifuge tubes.
+
#Add 0.5 mL of the WR to each 0.5 mL aliquot of the standard and to your 0.5 mL protein samples.
+
#Cap your tubes and incubate at 60&deg;C in the water bath for 1 hour. During this time download the sample data on the Discussion page to practice estimating protein concentration of your samples.
+
#Following the incubation, the teaching faculty will use the spectrophotometer to measure the protein concentrations of your standards and your purified samples.
+
#* The cuvette filled only with water (H) will be used as a blank in the spectrophotometer.
+
#*The absorbance at 562 nm for each solution will be measured and the results will be posted to today's [http://engineerbiology.org/wiki/Talk:20.109%28S16%29:Purify_protein_%28Day6%29 Discussion] page.
+
#* Establish your standard curve by plotting OD562 for each BSA standard (B-H) vs. its concentration in &mu;g/mL.
+
#* Use the standard curve in its linear range (0.5 - 20 &mu;g/mL), and its linear regression in Excel, to determine the protein concentration of each unknown sample (wild-type and mutant IPC).
+
  
==Reagents list==
+
[[Image:Sp21 M3D3 titration plate map.png|thumb|450px|right|'''Schematic of plate map used to prepare titration curve.''']]
  
 +
#Obtain a black 96-well plate and review the plate map schematic at right: the top two rows will be loaded with WT IPC, the next two rows will be loaded with your Variant IPC, and the final row will be loaded with BSA.
 +
#*BSA will be used to measure the background signal.
 +
#*A black plate is used to minimize "cross-talk" (''i.e.'', light leakage) between samples in adjacent wells.
 +
#Aliquot the WT IPC protein into the appropriate wells of the plate.
 +
#*Add 30 μL of the purified protein to each well in rows A and B.
 +
#Aliquot the Variant IPC protein into the appropriate wells of the plate.
 +
#*Add 30 μL of the purified protein to each well in rows C and D.
 +
#Aliquot 30 μL of 0.1% BSA to each of the wells in row E.
 +
#The calcium solutions are at the front bench in reservoirs that will be shared across the class. 
 +
#*'''Carefully''' carry your plate to the front bench to add these solutions. 
 +
#From shared reservoir #1 (calcium concentration = 0 nM), use the multi-channel pipet to add 30 μL to the top five rows in the first column of the plate. Discard the pipet tips.
 +
#Work from reservoirs #2 to #12 (lowest calcium concentration to highest calcium concentration), and from the left-hand to the right-hand columns on your plate.
 +
#*Be sure to use fresh pipet tips each time! If you do contaminate a solution, let the Instructor know so the solution can be replaced. Honesty about a mistake is far preferred here to affecting every downstream experiment.
 +
#When you are done, alert the Instructor and you will be taken in small groups to measure the fluorescence values for your samples.
 +
#Samples will be measured using a platereader.
 +
#*Settings included an excitation wavelength of 485 nm and an emission wavelength at 515 nm.
  
*QIAprep Spin Miniprep Kit reagents
+
<font color = #4a9152 >'''In your laboratory notebook,'''</font color> complete the following:
*Sequencing primers (concentration = 5 pmol/&mu;L)
+
*Recall your analysis of the SDS-PAGE and microBCA completed on M3D1. Were the Variant IPC and WT IPC concentrations consistent / similar across each of the purified protein samples?
*100 mM CaCl<sub>2</sub>, sterile
+
*Given that the same volume is added to each the titrations completed with each of Variant IPC and WT IPC (30 &micro;L of each purified protein sample was added), might this impact the results from the titration curve experiment?  How?
*LB (Luria-Bertani broth)
+
*What change(s) could be made to the protocol to ensure the same amount of Variant IPT or WT IPC was used in each titration curve experiment?  Be specific on how you might address this issue.
**1% Tryptone
+
**0.5% Yeast Extract
+
**1% NaCl
+
** autoclaved for sterility
+
*Ampicillin stock: 100 mg/mL, aqueous, sterile-filtered, store at +4 &deg;C
+
*Chloramphenicol stock: 34 mg/mL in ethanol, store at -20 &deg;C
+
  
*LB+AMP+CAM plates
+
===Part 3: Analyze titration curve data===
**LB with 1.5% agar and 100 &mu;g/mL ampicillin and 34 &mu;g/mL chloramphenicol
+
  
 +
You will analyze your calcium titration assay data in two steps. First, you will get a rough sense for how the mutations changed (or didn't) binding activity compared to WT IPC by plotting the averages of the two replicate values for each Variant IPC, in both raw and processed form. Second, you will take the average processed values and use  <small>MATLAB</small> code that will more precisely determine the affinity and cooperativity for the Variant IPC and WT  IPC with respect to calcium.
  
*IPTG (isopropyl &beta;-D-1-thiogalactoside), 0.1 M
+
The spreadsheet with the data that will be used for the analysis is linked [[Media:Sp21 Ca titration data for IPC and Variants.xlsx |here]].  In this spreadsheet, the fluorescence measurements for duplicate samples of WT IPC and each of the Variant IPC are provided.  The calcium concentrations (nM) are listed across the top of the spreadsheet.
  
 +
====Plot titration curve in Excel to determine first estimate of ''K<sub>d</sub>''====
  
*BugBuster Protein Extraction Reagent from EMD Millipore
+
Today you will analyze the fluorescence data for the WT IPC and six Variant IPC.  First, you will use Excel to visualize the raw data.  In addition, you will normalize the data to prepare for more advanced analysis using <small>MATLAB</small>.
**0.1% BSA
+
**1:200 protease inhibitors
+
**1:1000 nuclease enzyme
+
  
*6X Laemmli sample buffer from Boston BioProducts
+
#Open the Excel file linked above.
**2% SDS, 6% glycerol, 0.03% Bromophenol Blue in 375 mM Tris-HCl pH 6.8, + 9% &beta;-mercaptoethanol
+
#*In column A the samples that were measured are listed.  Because duplicates of each sample were measured, two values are provided in the table for the WT IPC and each Variant IPC.
 +
#*The calcium concentrations (nM) are provided in the top row.
 +
#Review the data provided in the Excel spreadsheet.
 +
#<font color =  #4a9152 >'''In your laboratory notebook,'''</font color> complete the following:
 +
#*Do the numbers make sense? Remember that IPC fluorescence decreases when calcium is bound.
 +
#*Are there any anomalies in the data (does anything appear strange / unexpected)?
 +
#Begin by calculating the averages for the duplicate samples.
 +
#To visualize the raw data, plot the averages for each sample (y-axis) as a function of calcium concentration (x-axis).  Be sure to change the x-axis to a log scale.
 +
#<font color =  #4a9152 >'''In your laboratory notebook,'''</font color> complete the following:
 +
#*Include the plot of the raw data.
 +
#*Briefly describe how each Variant IPC differs from the WT IPC.
 +
#Next you will normalize the data to the 0 nM calcium fluorescent value for each sample by converting all values to a percent.
 +
#Because the fluorescence measured at 0 nM calcium for each sample will be used to normalize the data, create a new table in the Excel spreadsheet containing each of the samples wherein this value will be set to "1".
 +
#*In the new table, each sample should be listed in the first column (as in the original spreadsheet) and the value for 0 nM calcium should be entered as "1" for each sample.
 +
#*This means that the fluorescence value measured for each of the samples at 0 nM calcium is now set at 100% in your data analysis.
 +
#To calculate the % fluorescence for the remaining calcium concentrations, divide by the fluorescence value measured for the 0 nM calcium condition.
 +
#*For example, if the 0 nM calcium fluorescence value for the WT IPC equals 1200, then the fluorescence values measured for calcium concentrations 8.5 nM through 19.5 &micro;M should be divided by 1200.
 +
#*This normalized value represents the % fluorescence for each calcium concentration based on the value at 0 nM calcium for each sample.
 +
#To visualize the normalized data, plot the % fluorescence values for each sample (y-axis) as a function of calcium concentration (x-axis).  Be sure to change the x-axis to a log scale.
 +
#<font color =  #4a9152 >'''In your laboratory notebook,'''</font color> complete the following:
 +
#*Include the plot of the normalized data.
 +
#*Briefly describe how each Variant IPC differs from the WT IPC.
 +
#*Does this plot look similar or different from the plot of the raw data?
 +
#*Can you estimate the K<sub>d</sub> from the binding curves in either the raw or normalized data plots?
  
*Protein purification supplies from Novagen/Calbiochem
+
====Use <small>MATLAB</small> modeling to estimate ''K<sub>d</sub>'' ====
**Ni-NTA His-Bind Resin
+
**1X Ni-NTA Bind Buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>, pH 8.0; 300 mM NaCl; 10 mM imidazole)
+
**1X Ni-NTA Wash Buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>, pH 8.0; 300 mM NaCl; 20 mM imidazole)
+
**1X Ni-NTA Elute Buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>, pH 8.0; 300 mM NaCl; 250 mM imidazole)
+
  
*Zeba Desalt Spin Columns from Thermo Scientific
+
Next you will use the normalized data generated above to determine the K<sub>d</sub> by fitting the data to a curve in <small>MATLAB</small>.
**7000 Da MW cut-off
+
  
*Micro BCA Protein Assay Kit from Thermo Scientific
+
#Create a folder in <small>MATLAB</small> and upload the following scripts: [[Media:F15 Fit Main.m  | F15_Fit_Main]], [[Media:Fit_SingleKD.m| Fit_SingleKD]], and [[Media:Fit_KDn.m| Fit_KDn]]
**Micro BCA Reagent A (MA)
+
#In <small>MATLAB</small>, open the folder with the above files then double-click on 'F15_Fit_Main'.
**Micro BCA Reagent B (MB)
+
#*Read through the script, particularly the introductory comments (indicated by the % sign) to learn more about what is accomplished by each step in the code.
**Micro BCA Reagent C (MC)
+
#*If you encounter unfamiliar terms, return to the workspace and type ''help functionname'' for a description of the command.
**Bovine Serum Albumin Standard, 2 mg/mL
+
#Place your cursor at line 1 and click to highlight the first section of the code.
 +
#Click 'Run section'.
 +
#*This will clear the workspace such that parameters set previously do not interfere with the analysis.
 +
#Enter the normalized fluorescence values for the WT IPC, Variant #1 IPC, and Variant #2 IPC where indicated.
 +
#*Currently placeholder values are entered.  Simply delete the placeholder values and enter your data.
 +
#Place your cursor at line 10 and click to highlight the section of code.
 +
#Click 'Run section' to execute the code.
 +
#*The functions in this section will calculate the binding fractions from the fluorescence data entered.
 +
#<font color =  #4a9152 >'''In your laboratory notebook,'''</font color> complete the following:
 +
#*Consider the equation used in the <small>MATLAB</small> code to calculate fraction bound.  How does fraction bound relate to the fluorescence values measured?
 +
#*Why is it necessary to use the fraction bound (rather than the fluorescence data) in determining the ''K<sub>d</sub>''?
 +
#Place your cursor at line 35 and click to highlight Part 1: Fit for single ''K<sub>d</sub>'' value using a simple model.
 +
#*This script uses the nonlinear fitting tool to determine ''K<sub>d</sub>'' values according to the model defined in 'Fit_SingleKD', which ignores multiple ligand sites and provides a simplified representation of binding.
 +
#Click 'Run section' to execute the code.
 +
#Examine the graphs (Figure 1 and Figure 2) generated in <small>MATLAB</small>.
 +
#*Figure 1 includes graphs for the WT IPC and each Variant IPC wherein the data points and model curves are displayed.
 +
#*Figure 2 is a graph displaying the residuals, or difference between the data and the model, of the WT IPC and each Variant IPC.  If the absolute values are low, this indicates good agreement between the model and the data numerically. Whether or not this is the case, another thing to look for is whether the residuals are evenly and randomly distributed about the zero-line. If there is a pattern to the errors, likely there is a systematic difference between the data and the model, and thus the model does not reflect the actual binding process well.
 +
#Examine the ''K<sub>d</sub>'' values that were calculated using this model.
 +
#*These values should be present in the Command Window.
 +
#<font color =  #4a9152 >'''In your laboratory notebook,'''</font color> complete the following:
 +
#*Include all graphs.
 +
#*Record the ''K<sub>d</sub>'' values.
 +
#*How do the graphs generated in Figure 1 compare to the graph you plotted in Excel?
 +
#*What does the residuals graph tell you about the fit of your data to the model?
 +
#Place your cursor at line 108 and click to highlight Part 2: Model for single ''K<sub>d</sub>'' plus Hill coefficient, Method 1.
 +
#*This script uses a function that more appropriately represents the binding behavior of IPC according to the model defined in 'Fit_KDn', which allows for multiple binding sites and tests for cooperativity among them. The parameter used to measure cooperativity is called the Hill coefficient. A Hill coefficient of 1 indicates independent binding sites, while greater or lesser values reflect positive or negative cooperativity, respectively.
 +
#Click 'Run section' to execute the code.
 +
#Examine the graphs (Figure 3 and Figure 4) generated in <small>MATLAB</small>.
 +
#*Figure 3 includes graphs for the WT IPC and each Variant IPC wherein the data points and model curves are displayed.
 +
#*Figure 4 is a graph displaying the residuals.
 +
#<font color =  #4a9152 >'''In your laboratory notebook,'''</font color> complete the following:
 +
#*Include all graphs.
 +
#*Record the ''K<sub>d</sub>'' values and Hill coefficients.
 +
#*Which model appears to better fit the WT IPC data (consider Figure 1 vs Figure 3 AND Figure 2 vs Figure 4)?  The Variant IPC data?
 +
#Part 3: Model for single ''K<sub>d</sub>'' plus Hill coefficient, Method 2 is entirely optional if you are interested in another function available for defining ''K<sub>d</sub>'' and Hill coefficient.
 +
#*If you choose to use this script, be sure to update the range of the linear transition region for each sample.
 +
#Lastly, analyze your data using a model able to account for two <math>K_d</math> values.
 +
#*Upload the following scripts to your <small>MATLAB</small> folder: [[Media:Fit_TwoKD.m |Fit_TwoKD]] and [[Media:Fit_TwoKD_Func.m | Fit_TwoKD_Func]]
 +
#Double-click on 'Fit_TwoKD'.
 +
#*Read through the script, then then enter the normalized fluorescence values for the WT IPC where indicated.  Note: in this script only one sample can be analyzed at a time!
 +
#*Currently placeholder values are entered.  Simply delete the placeholder values and enter your data.
 +
#Click 'Run' to execute the code.
 +
#Examine the graph that was generated in <small>MATLAB</small>.
 +
#Examine the output values that were calculated using this model.
 +
#<font color =  #4a9152 >'''In your laboratory notebook,'''</font color> complete the following:
 +
#*Include all graphs.
 +
#*Record the f, ''K<sub>d</sub>'', and n values.  What do the f and n values represent?
 +
#*Of all of the models examined, which best represents the WT IPC binding data?
 +
#To complete the data analysis for all of the Variant IPC, complete the above steps such that each Variant IPC is analyzed using the models included at Steps #9, #14, and #19.  You can do this by simply running the code in multiple rounds such that each Variant IPC is analyzed or, if you are comfortable with the code, you can edit the script such that all samples can be analyzed together.
 +
#<font color =  #4a9152 >'''In your laboratory notebook,'''</font color> complete the following:
 +
#*Include all graphs and data for each Variant IPC.
 +
#*Describe how each mutation altered binding and / or cooperativity of the Variant IPC compared to WT IPC.
  
 
==Navigation links==
 
==Navigation links==
Next day: [[20.109(S21):M3D4 |Evaluate effect of mutations on IPC variants ]] <br>
+
Next day: [[20.109(S21):M3D4 |Design new IPC variant ]] <br>
Previous day: [[20.109(S21):M3D2 |Examine IPC mutations ]] <br>
+
Previous day: [[20.109(S21):M3D2 |Identify IPC mutations]] <br>

Latest revision as of 15:12, 4 May 2021

20.109(S21): Laboratory Fundamentals of Biological Engineering

Sp21 banner image v2.png

Spring 2021 schedule        FYI        Assignments        Homework        Communication |        Accessibility

       M1: Antibody engineering        M2: Drug discovery        M3: Protein engineering       


Introduction

To test the effects of the mutations in the Variant IPC proteins, we will revisit several concepts that were discussed in Mod1. Specifically, a titration curve is used to calculate $ K_d $ of IPC binding to calcium! As a review, consider the simple case of a receptor-ligand pair that are exclusive to each other, and in which the receptor is monovalent. The ligand (L) and receptor (R) form a complex (C), which can be written

$ R + L \rightleftharpoons\ ^{k_f}_{k_r} C $

At equilibrium, the rates of the forward reaction (rate constant = $ k_f $) and reverse reaction (rate constant = $ k_r $) must be equivalent. Solving this equivalence yields an equilibrium dissociation constant $ K_d $, which may be defined either as $ k_r/k_f $, or as $ [R][L]/[C] $, where brackets indicate the molar concentration of a species. Meanwhile, the fraction of receptors that are bound to ligand at equilibrium, often called y or θ, is $ C/R_{TOT} $, where $ R_{TOT} $ indicates total (both bound and unbound) receptors. Note that the position of the equilibrium (i.e., y) depends on the starting concentrations of the reactants; however, $ K_d $ is always the same value. The total number of receptors $ R_{TOT} $= [C] (ligand-bound receptors) + [R] (unbound receptors). Thus,

$ \qquad y = {[C] \over R_{TOT}} \qquad = \qquad {[C] \over [C] + [R]} \qquad = \qquad {[L] \over [L] + [K_d]} \qquad $

where the right-hand equation was derived by algebraic substitution. If the ligand concentration is in excess of the concentration of the receptor, [L] may be approximated as a constant, L, for any given equilibrium. Let’s explore the implications of this result:

  • What happens when L << $ K_d $?
→Then y ~ $ L/K_d $, and the binding fraction increases in a first-order fashion, directly proportional to L.
  • What happens when L >> $ K_d $?
→In this case y ~1, so the binding fraction becomes approximately constant, and the receptors are saturated.
  • What happens when L = $ K_d $?
→Then y = 0.5, and the fraction of receptors that are bound to ligand is 50%. When y = 0.5, the concentration of free calcium (our [L]) is equal to $ K_d $.

The figures below demonstrate how to read $ K_d $ from binding curves:

Simple binding curve
The binding fraction y at first increases linearly as the starting ligand concentration is increased, then asymptotically approaches full saturation (y=1). The dissociation constant $ K_d $ is equal to the ligand concentration [L] for which y = 1/2.

Semilog binding curves
By converting ligand concentrations to logspace, the dissociation constant is readily determined from the inflection point of the sigmoidal curve. The three curves each represent different ligand species. The middle curve has a $ K_d $ close to 10 nM, while the right-hand curve has a higher $ K_d $ and therefore lower affinity between ligand and receptor (vice-versa for the left-hand curve).

Binding curves are used to determine $ K_d $. Titration data can be visualized using simple, also referred to as linear, plots (A) or semilog plots (B). In both representations, every L value is associated with a particular equilbrium value of y, while the curve as a whole gives information on the global equilibrium constant $ K_d $.

Because inverse pericam has multiple binding sites the IPC-calcium binding is more complicated than the example above. The $ K_d $ reported in the IPC reference article by Nagai et. al. is called an ‘apparent $ K_d $’ because it reflects the overall avidity of multiple calcium binding sites, not their individual affinities for calcium. Normally, calmodulin has a low affinity (N-terminus) and a high affinity (C-terminus) pair of calcium binding sites. However, the E104Q mutant, which is the version of CaM used in inverse pericam, displays low affinity binding at both termini. Moreover, the Hill coefficient, which quantifies cooperativity of binding in the case of multiple sites, is reported to be 1.0 for inverse pericam. This indicates that inverse pericam behaves as if it were binding only a single calcium ion per molecule. Thus, wild-type IPC is well-described by a single apparent $ K_d $.

For any given variant IPC, things may be more complicated. Keep in mind that we are not directly measuring calcium binding, but instead are indirectly inferring it based on fluorescence. A change in fluorescence requires the participation not only of calcium, but also of M13. In addition to the four separate calcium binding sites in calmodulin, the M13 binding site influences apparent affinity and apparent cooperativity. In short, be careful about how you describe the meanings of our binding parameters in your data analysis.

Protocols

Part 1: Participate in Comm Lab workshop

Our communication instructors, Dr. Prerna Bhargava and Dr. Sean Clarke, will join us today for a discussion on preparing a Research proposal presentation.

Part 2: Prepare samples for titration curve

Schematic of plate map used to prepare titration curve.
  1. Obtain a black 96-well plate and review the plate map schematic at right: the top two rows will be loaded with WT IPC, the next two rows will be loaded with your Variant IPC, and the final row will be loaded with BSA.
    • BSA will be used to measure the background signal.
    • A black plate is used to minimize "cross-talk" (i.e., light leakage) between samples in adjacent wells.
  2. Aliquot the WT IPC protein into the appropriate wells of the plate.
    • Add 30 μL of the purified protein to each well in rows A and B.
  3. Aliquot the Variant IPC protein into the appropriate wells of the plate.
    • Add 30 μL of the purified protein to each well in rows C and D.
  4. Aliquot 30 μL of 0.1% BSA to each of the wells in row E.
  5. The calcium solutions are at the front bench in reservoirs that will be shared across the class.
    • Carefully carry your plate to the front bench to add these solutions.
  6. From shared reservoir #1 (calcium concentration = 0 nM), use the multi-channel pipet to add 30 μL to the top five rows in the first column of the plate. Discard the pipet tips.
  7. Work from reservoirs #2 to #12 (lowest calcium concentration to highest calcium concentration), and from the left-hand to the right-hand columns on your plate.
    • Be sure to use fresh pipet tips each time! If you do contaminate a solution, let the Instructor know so the solution can be replaced. Honesty about a mistake is far preferred here to affecting every downstream experiment.
  8. When you are done, alert the Instructor and you will be taken in small groups to measure the fluorescence values for your samples.
  9. Samples will be measured using a platereader.
    • Settings included an excitation wavelength of 485 nm and an emission wavelength at 515 nm.

In your laboratory notebook, complete the following:

  • Recall your analysis of the SDS-PAGE and microBCA completed on M3D1. Were the Variant IPC and WT IPC concentrations consistent / similar across each of the purified protein samples?
  • Given that the same volume is added to each the titrations completed with each of Variant IPC and WT IPC (30 µL of each purified protein sample was added), might this impact the results from the titration curve experiment? How?
  • What change(s) could be made to the protocol to ensure the same amount of Variant IPT or WT IPC was used in each titration curve experiment? Be specific on how you might address this issue.

Part 3: Analyze titration curve data

You will analyze your calcium titration assay data in two steps. First, you will get a rough sense for how the mutations changed (or didn't) binding activity compared to WT IPC by plotting the averages of the two replicate values for each Variant IPC, in both raw and processed form. Second, you will take the average processed values and use MATLAB code that will more precisely determine the affinity and cooperativity for the Variant IPC and WT IPC with respect to calcium.

The spreadsheet with the data that will be used for the analysis is linked here. In this spreadsheet, the fluorescence measurements for duplicate samples of WT IPC and each of the Variant IPC are provided. The calcium concentrations (nM) are listed across the top of the spreadsheet.

Plot titration curve in Excel to determine first estimate of Kd

Today you will analyze the fluorescence data for the WT IPC and six Variant IPC. First, you will use Excel to visualize the raw data. In addition, you will normalize the data to prepare for more advanced analysis using MATLAB.

  1. Open the Excel file linked above.
    • In column A the samples that were measured are listed. Because duplicates of each sample were measured, two values are provided in the table for the WT IPC and each Variant IPC.
    • The calcium concentrations (nM) are provided in the top row.
  2. Review the data provided in the Excel spreadsheet.
  3. In your laboratory notebook, complete the following:
    • Do the numbers make sense? Remember that IPC fluorescence decreases when calcium is bound.
    • Are there any anomalies in the data (does anything appear strange / unexpected)?
  4. Begin by calculating the averages for the duplicate samples.
  5. To visualize the raw data, plot the averages for each sample (y-axis) as a function of calcium concentration (x-axis). Be sure to change the x-axis to a log scale.
  6. In your laboratory notebook, complete the following:
    • Include the plot of the raw data.
    • Briefly describe how each Variant IPC differs from the WT IPC.
  7. Next you will normalize the data to the 0 nM calcium fluorescent value for each sample by converting all values to a percent.
  8. Because the fluorescence measured at 0 nM calcium for each sample will be used to normalize the data, create a new table in the Excel spreadsheet containing each of the samples wherein this value will be set to "1".
    • In the new table, each sample should be listed in the first column (as in the original spreadsheet) and the value for 0 nM calcium should be entered as "1" for each sample.
    • This means that the fluorescence value measured for each of the samples at 0 nM calcium is now set at 100% in your data analysis.
  9. To calculate the % fluorescence for the remaining calcium concentrations, divide by the fluorescence value measured for the 0 nM calcium condition.
    • For example, if the 0 nM calcium fluorescence value for the WT IPC equals 1200, then the fluorescence values measured for calcium concentrations 8.5 nM through 19.5 µM should be divided by 1200.
    • This normalized value represents the % fluorescence for each calcium concentration based on the value at 0 nM calcium for each sample.
  10. To visualize the normalized data, plot the % fluorescence values for each sample (y-axis) as a function of calcium concentration (x-axis). Be sure to change the x-axis to a log scale.
  11. In your laboratory notebook, complete the following:
    • Include the plot of the normalized data.
    • Briefly describe how each Variant IPC differs from the WT IPC.
    • Does this plot look similar or different from the plot of the raw data?
    • Can you estimate the Kd from the binding curves in either the raw or normalized data plots?

Use MATLAB modeling to estimate Kd

Next you will use the normalized data generated above to determine the Kd by fitting the data to a curve in MATLAB.

  1. Create a folder in MATLAB and upload the following scripts: F15_Fit_Main, Fit_SingleKD, and Fit_KDn
  2. In MATLAB, open the folder with the above files then double-click on 'F15_Fit_Main'.
    • Read through the script, particularly the introductory comments (indicated by the % sign) to learn more about what is accomplished by each step in the code.
    • If you encounter unfamiliar terms, return to the workspace and type help functionname for a description of the command.
  3. Place your cursor at line 1 and click to highlight the first section of the code.
  4. Click 'Run section'.
    • This will clear the workspace such that parameters set previously do not interfere with the analysis.
  5. Enter the normalized fluorescence values for the WT IPC, Variant #1 IPC, and Variant #2 IPC where indicated.
    • Currently placeholder values are entered. Simply delete the placeholder values and enter your data.
  6. Place your cursor at line 10 and click to highlight the section of code.
  7. Click 'Run section' to execute the code.
    • The functions in this section will calculate the binding fractions from the fluorescence data entered.
  8. In your laboratory notebook, complete the following:
    • Consider the equation used in the MATLAB code to calculate fraction bound. How does fraction bound relate to the fluorescence values measured?
    • Why is it necessary to use the fraction bound (rather than the fluorescence data) in determining the Kd?
  9. Place your cursor at line 35 and click to highlight Part 1: Fit for single Kd value using a simple model.
    • This script uses the nonlinear fitting tool to determine Kd values according to the model defined in 'Fit_SingleKD', which ignores multiple ligand sites and provides a simplified representation of binding.
  10. Click 'Run section' to execute the code.
  11. Examine the graphs (Figure 1 and Figure 2) generated in MATLAB.
    • Figure 1 includes graphs for the WT IPC and each Variant IPC wherein the data points and model curves are displayed.
    • Figure 2 is a graph displaying the residuals, or difference between the data and the model, of the WT IPC and each Variant IPC. If the absolute values are low, this indicates good agreement between the model and the data numerically. Whether or not this is the case, another thing to look for is whether the residuals are evenly and randomly distributed about the zero-line. If there is a pattern to the errors, likely there is a systematic difference between the data and the model, and thus the model does not reflect the actual binding process well.
  12. Examine the Kd values that were calculated using this model.
    • These values should be present in the Command Window.
  13. In your laboratory notebook, complete the following:
    • Include all graphs.
    • Record the Kd values.
    • How do the graphs generated in Figure 1 compare to the graph you plotted in Excel?
    • What does the residuals graph tell you about the fit of your data to the model?
  14. Place your cursor at line 108 and click to highlight Part 2: Model for single Kd plus Hill coefficient, Method 1.
    • This script uses a function that more appropriately represents the binding behavior of IPC according to the model defined in 'Fit_KDn', which allows for multiple binding sites and tests for cooperativity among them. The parameter used to measure cooperativity is called the Hill coefficient. A Hill coefficient of 1 indicates independent binding sites, while greater or lesser values reflect positive or negative cooperativity, respectively.
  15. Click 'Run section' to execute the code.
  16. Examine the graphs (Figure 3 and Figure 4) generated in MATLAB.
    • Figure 3 includes graphs for the WT IPC and each Variant IPC wherein the data points and model curves are displayed.
    • Figure 4 is a graph displaying the residuals.
  17. In your laboratory notebook, complete the following:
    • Include all graphs.
    • Record the Kd values and Hill coefficients.
    • Which model appears to better fit the WT IPC data (consider Figure 1 vs Figure 3 AND Figure 2 vs Figure 4)? The Variant IPC data?
  18. Part 3: Model for single Kd plus Hill coefficient, Method 2 is entirely optional if you are interested in another function available for defining Kd and Hill coefficient.
    • If you choose to use this script, be sure to update the range of the linear transition region for each sample.
  19. Lastly, analyze your data using a model able to account for two $ K_d $ values.
  20. Double-click on 'Fit_TwoKD'.
    • Read through the script, then then enter the normalized fluorescence values for the WT IPC where indicated. Note: in this script only one sample can be analyzed at a time!
    • Currently placeholder values are entered. Simply delete the placeholder values and enter your data.
  21. Click 'Run' to execute the code.
  22. Examine the graph that was generated in MATLAB.
  23. Examine the output values that were calculated using this model.
  24. In your laboratory notebook, complete the following:
    • Include all graphs.
    • Record the f, Kd, and n values. What do the f and n values represent?
    • Of all of the models examined, which best represents the WT IPC binding data?
  25. To complete the data analysis for all of the Variant IPC, complete the above steps such that each Variant IPC is analyzed using the models included at Steps #9, #14, and #19. You can do this by simply running the code in multiple rounds such that each Variant IPC is analyzed or, if you are comfortable with the code, you can edit the script such that all samples can be analyzed together.
  26. In your laboratory notebook, complete the following:
    • Include all graphs and data for each Variant IPC.
    • Describe how each mutation altered binding and / or cooperativity of the Variant IPC compared to WT IPC.

Navigation links

Next day: Design new IPC variant

Previous day: Identify IPC mutations